Examination for the effect of eldecalcitol on muscle strength in primary osteoporotic patients
Not Applicable
Recruiting
- Conditions
- Osteoporosis
- Registration Number
- JPRN-UMIN000008464
- Lead Sponsor
- TT East Tohoku Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with contraindication for bisphosphonate treatments 2. Patients with contraindication for eldecalcitol treatments 3. Patients who are treated with active vitamin D drugs within 8 weeks 4. Patients who have serum calcium levels of above 10.5mg/dL 5. Patients who are inappropriate for this study by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method At baseline and after 24 weeks follow up, the following assessments are done. back muscle strength, hand grip strength, quadriceps muscle strength
- Secondary Outcome Measures
Name Time Method lumbar spine bone mineral density hip bone mineral density 25(OH)D one leg stand test, walking test, timed up and go test, number of falls, active mass, QOL, Safety